People affected with bacterial infections can be involved in every step of antibiotic drug development. Not only can they be receiving an antibiotic treatment that derives from research results, but they can also be contributing partners of research, and even involved in further research. During this Science Communication Interest Group meeting, we explored community engagement on three levels:
1) the right language to use when communicating with people affected by infectious diseases like tuberculosis (TB);
2) involving the public in antimicrobial development research (research partners);
3) engaging with AMR-affected people as research participants.
We also discussed the experiences of members of the SCIG, listening to the following short presentations that helped frame discussions responding to project needs in terms of language guidance and good practices for communicating & engaging with AMR-affected people on all three levels.